LINC02264: A Potential Drug Target and Biomarker (G105377391)

Target Name: LINC02264

NCBI ID: G105377391

LINC02264

Other Name(s): Uncharacterized LOC105377391 | LOC105377391 | Long intergenic non-protein coding RNA 2264 | long intergenic non-protein coding RNA 2264

LINC02264: A Potential Drug Target and Biomarker

LINC02264 is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of cellular processes that are important for maintaining tissue health and function.

Recent studies have suggested that LINC02264 may be a drug target that can be targeted with small molecules. This protein is also known to have been implicated in the development of certain diseases, which has led some researchers to consider it as a potential biomarker for these diseases.

The protein encoded by the LINC02264 gene is made up of 1,122 amino acids and has a calculated molecular weight of 18.8 kDa. It is located on chromosome 6q24 and has been shown to be expressed in a variety of tissues and cells, including the brain, heart, liver, and kidney.

One of the key functions of LINC02264 is its role in the regulation of mitochondrial function. Mitochondria are organelles that are responsible for generating energy for the cell through a process called cellular respiration. LINC02264 is known to be involved in the regulation of the expression of genes that are involved in mitochondrial function, which is important for the survival and function of the cell.

In addition to its role in mitochondrial function, LINC02264 is also involved in the regulation of cellular signaling pathways. It has been shown to be involved in a variety of signaling pathways, including the NF-kappa pathway and the Wnt pathway. These signaling pathways are important for the development and maintenance of tissues and organs, and LINC02264 may be a potential drug target that can be targeted with small molecules.

The potential drug target for LINC02264 is related to its role in the regulation of mitochondrial function and cellular signaling pathways. It is thought that small molecules that can modulate the activity of LINC02264 may be effective in treating diseases that are related to these processes.

In addition to its potential drug target, LINC02264 has also been suggested as a potential biomarker for a variety of diseases. For example, LINC02264 has been shown to be elevated in the blood of individuals with certain diseases, such as heart disease and diabetes. This suggests that LINC02264 may be a useful biomarker for these diseases, and that its levels can be used as a diagnostic tool.

Further research is needed to fully understand the function of LINC02264 and its potential as a drug target and biomarker. Study of the molecular mechanisms that are involved in its function may provide insights into the mechanisms underlying the development and progression of many diseases.

In conclusion, LINC02264 is a protein that is expressed in various tissues of the human body and is involved in the regulation of mitochondrial function and cellular signaling pathways. Its potential as a drug target and biomarker has led to a significant amount of interest and research in this protein, and further study is needed to fully understand its function and potential applications in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 2264

The "LINC02264 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02264 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets